In response to inquiries from researchers, Shanghai Pharmaceuticals Holding Co., Ltd. indicated that its industrial segment covers a wide range of areas including chemical and biological drugs, modern traditional Chinese medicines and health supplements, as well as medical devices. The company focuses on disease areas such as immunology, neuropsychiatry, oncology, cardiovascular, digestive and metabolic disorders, and anti-infectives. It operates pharmaceutical production bases across 12 provinces and municipalities in China and overseas, consistently manufacturing approximately 800 drug specifications across more than 30 dosage forms. In 2025, the company had 40 products with industrial sales exceeding 100 million yuan, including four products with sales surpassing 1 billion yuan.